Nádia Armelin is a chemical engineer with a strong background in digital innovation and leadership. Since 2019, she has been a partner at Aggir Ventures Health, managing a healthcare-focused venture capital fund investing in Brazilian companies. A Six Sigma Black Belt, Edmund Hillary Fellow, and Harvard Business School GMP alumna, Nadia combines expertise in technology, healthcare, and business management.
Investor Profile
Based In: São Paulo, Brazil
Board Positions: Upflu, Salu, Medway, Nefroclinicas, Agora Consulta
Investor Type: VC Firm
Preferred Sector(s): Healthcare
Preferred Stage(s): Early and mid-stage healthcare companies
Preferred Geo(s): Brazil, Latin America
Website: https://salu.com.vc/
LAVCA Honors
Top Women Investors in Latin America 2024